The patent, when formally approved, will reinforce protection for Silo's lead asset, SPC-15, an intranasal treatment ...

Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a late-stage pharmaceutical company with a broad ...

"We believe that 2025 will be a pivotal year for SELLAS as we continue to advance our clinical stage portfolio of novel therapeutics for hematologic malignancies,” said Angelos ...

Sexual counseling and education based on self-efficacy theory improved sexual function in women with breast cancer, enhancing ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

France’ s health ministry today reported the country ’ s first clade 1b mpox case, which involves a person from Brittany who ...

Researchers at The Clatterbridge Cancer Centre NHS Foundation Trust are using AI to enhance the precision of radiotherapy for ...